NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hummsa Biotech

Hummsa Biotech

Private
KolkataHealthcare & Life Scienceshttps://www.hummsabiotech.com/

Last Round

Seed

Jun 1, 2024

Total Funding Raised

$150,000

Company Overview

Hummsa Biotech is a biotechnology company that develops next-generation oral GLP-1 small-molecule therapies and diagnostics for metabolic diseases such as diabetes and obesity.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

oral GLP-1small molecule discoverymetabolic disease therapeuticsGLP-1 receptor agonistdrug discoverypreclinical biotechobesity treatmentdiabetes treatmentfatty liver diseasecell regeneration therapynanotechnology diagnosticssepsis diagnosticsaptamer diagnosticsAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hummsa Biotech Comparables

Compare Hummsa Biotech with similar companies based on industry and business-model similarity.

Hummsa Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Hummsa Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 1, 2024
AcceleratorMar 1, 2023
View all Funding Rounds

Key People

Founding team and executive leadership

Harshad Lalwani

Chief Executive Officer

Executive Team

Mayukh Bose

Chief Operating Officer

Executive Team

Hummsa Biotech Investors

Notable investors and investment history

Hummsa Biotech investors
InvestorRounds
100X.VCSeed
Centre for Innovation and Entrepreneurship, IIIT Hyderabad (CIE)Accelerator
International Institute of Information Technology, HyderabadAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2024

    $150K round led by 100X.VC

  • Mar 1, 2023

    Received funding from CIE, IIIT Hyderabad.

View all signals

Hummsa Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hummsa Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hummsa Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersKolkata
Employee Range2
Year Founded2022
Last FundingJun 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.